Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Buyer: HHS-NIH11  |  Est. Value: Unspecified  |  Deadline: 2028-01-07

Scope Overview

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-286. Status: posted.

AI-Generated Compliance Checklist Preview

• 1. Eligibility & Registration (Mandatory): Confirm active vendor registration for HHS-NIH11 (US Federal).
  Required Evidence: Tax ID / Entity Registration / UEI or Company Number
• 2. Technical Scope Alignment (Mandatory): Address primary deliverables in "Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)".
  Required Evidence: 2 relevant past performance case studies & delivery methodology
• 3. Schedule & Submission Window (Critical): Submit complete package before 2028-01-07 (421 days left).
  Required Evidence: Signed cover letter + submission confirmation receipt
• 4. Commercial Pricing Sheet (Mandatory): Provide transparent fixed/T&M pricing aligned with Unspecified ceiling.
  Required Evidence: Rate card, labor/hardware breakdown, assumptions & exclusions